Kostas Arnaoutakis
@karnaoutakis.bsky.social
Son, Brother, Husband, Friend, medical oncologist, thoracic oncologist, educator
Reposted by Kostas Arnaoutakis
Wonderful story about a great addition to the McCormick Conference Center where our annual @ascocancer.bsky.social American Society for Clinical Oncology meeting takes place. 🦅
Look forward to checking this out next week at ASCO 2025!
www.nytimes.com/2025/05/20/c... #oncsky
Look forward to checking this out next week at ASCO 2025!
www.nytimes.com/2025/05/20/c... #oncsky
An Illinois Building Was a Bird Killer. A Simple Change Made a World of Difference.
www.nytimes.com
May 21, 2025 at 3:25 PM
Wonderful story about a great addition to the McCormick Conference Center where our annual @ascocancer.bsky.social American Society for Clinical Oncology meeting takes place. 🦅
Look forward to checking this out next week at ASCO 2025!
www.nytimes.com/2025/05/20/c... #oncsky
Look forward to checking this out next week at ASCO 2025!
www.nytimes.com/2025/05/20/c... #oncsky
Reposted by Kostas Arnaoutakis
The time relegated to being data clerks among US physicians is increasing
jamanetwork.com/journals/jam...
jamanetwork.com/journals/jam...
Trends in Physician Electronic Health Record Time and Message Volume
This cohort study uses national electronic health record data to assess patient medical advice request message volume and the time physicians spend in the records.
jamanetwork.com
February 24, 2025 at 5:25 PM
The time relegated to being data clerks among US physicians is increasing
jamanetwork.com/journals/jam...
jamanetwork.com/journals/jam...
Reposted by Kostas Arnaoutakis
Dr. Bryant Lin, who teaches medicine at Stanford University, was given a terminal cancer diagnosis. Instead of pulling back from work, he chose to spend the fall quarter teaching a course about his own illness.
When This Stanford Professor Got Cancer, He Decided to Teach a Class About It
Dr. Bryant Lin, who teaches medicine at Stanford University, was given a terminal diagnosis. He wanted his students to understand the humanity at the core of medicine.
www.nytimes.com
February 26, 2025 at 4:03 PM
Dr. Bryant Lin, who teaches medicine at Stanford University, was given a terminal cancer diagnosis. Instead of pulling back from work, he chose to spend the fall quarter teaching a course about his own illness.
Reposted by Kostas Arnaoutakis
Publication by @ascocancer.bsky.social on academic medical oncology. Makes me wonder- how do we encourage more transparency among institutions to set these standards ? ascopubs.org/doi/10.1200/...
Promoting Reasonable Career Expectations and Maximizing Professional Fulfillment for Academic Oncologists: ASCO Recommendations for Academic Medical Centers
In this statement, ASCO encourages academic medical centers to change their policies
and expectations to enhance and promote the professional fulfillment of academic medical
oncologists. The statement...
ascopubs.org
February 12, 2025 at 2:48 AM
Publication by @ascocancer.bsky.social on academic medical oncology. Makes me wonder- how do we encourage more transparency among institutions to set these standards ? ascopubs.org/doi/10.1200/...
Reposted by Kostas Arnaoutakis
Reposted by Kostas Arnaoutakis
Instead of listing my publications, as the year draws to an end, I want to shine the spotlight on the commonplace assumption that productivity must always increase. Good research is disruptive and thinking time is central to high quality scholarship and necessary for disruptive research.
December 20, 2024 at 11:18 AM
Instead of listing my publications, as the year draws to an end, I want to shine the spotlight on the commonplace assumption that productivity must always increase. Good research is disruptive and thinking time is central to high quality scholarship and necessary for disruptive research.
Reposted by Kostas Arnaoutakis
#ClinicalTrials can be tough to decode, but this excellent open-access guide makes it easier to understand terms like progression-free survival & others.
We’ll def be sharing with our #EGFR #LungCancer community. Big 🙏 to @lungoncdoc.bsky.social & co!
👉 www.tandfonline.com/doi/full/10.... #LCSM
We’ll def be sharing with our #EGFR #LungCancer community. Big 🙏 to @lungoncdoc.bsky.social & co!
👉 www.tandfonline.com/doi/full/10.... #LCSM
Decoding clinical trial jargon: helping people understand the efficacy end points used in cancer trials
People living with cancer should have access to clear and comprehensible treatment information to empower informed decision-making. With the increasing adoption of open access publishing and plain-...
www.tandfonline.com
December 21, 2024 at 8:24 AM
#ClinicalTrials can be tough to decode, but this excellent open-access guide makes it easier to understand terms like progression-free survival & others.
We’ll def be sharing with our #EGFR #LungCancer community. Big 🙏 to @lungoncdoc.bsky.social & co!
👉 www.tandfonline.com/doi/full/10.... #LCSM
We’ll def be sharing with our #EGFR #LungCancer community. Big 🙏 to @lungoncdoc.bsky.social & co!
👉 www.tandfonline.com/doi/full/10.... #LCSM
Reposted by Kostas Arnaoutakis
Thanks, Dr. Eric Singhi @lungoncdoc.bsky.social, for putting together this compilation of all the 2024 FDA #lungcancer approvals! Progress is real! #LCSM
December 10, 2024 at 11:30 PM
Thanks, Dr. Eric Singhi @lungoncdoc.bsky.social, for putting together this compilation of all the 2024 FDA #lungcancer approvals! Progress is real! #LCSM
Reposted by Kostas Arnaoutakis
After the medicine Nobel was given to Victor Ambros but not his wife (and 1st author on their landmark paper) Rosalind Lee, I got curious about what their story has to teach us about incentive structures in science. The reality is at once messier and more profound:
www.statnews.com/2024/12/06/n...
www.statnews.com/2024/12/06/n...
Inside a Nobel-winning marriage: They see each other as scientific equals, even if the prize committee doesn't
Ambros and Lee's collaboration helped spawn a new field of biology while proving breakthrough science can come out of a family-friendly lab
www.statnews.com
December 6, 2024 at 5:53 PM
After the medicine Nobel was given to Victor Ambros but not his wife (and 1st author on their landmark paper) Rosalind Lee, I got curious about what their story has to teach us about incentive structures in science. The reality is at once messier and more profound:
www.statnews.com/2024/12/06/n...
www.statnews.com/2024/12/06/n...
Reposted by Kostas Arnaoutakis
Big news. Dr. Druker literally tranformed care for chronic myelogenous leukemia.
His rationale for stepping down is a warning to centers everywhere - innovation takes vision and sustained commitment.
Lose the mission, lose the team.
His rationale for stepping down is a warning to centers everywhere - innovation takes vision and sustained commitment.
Lose the mission, lose the team.
December 4, 2024 at 10:26 AM
Big news. Dr. Druker literally tranformed care for chronic myelogenous leukemia.
His rationale for stepping down is a warning to centers everywhere - innovation takes vision and sustained commitment.
Lose the mission, lose the team.
His rationale for stepping down is a warning to centers everywhere - innovation takes vision and sustained commitment.
Lose the mission, lose the team.
Congratulations to the @uamshealth
Hematology/Medical Oncology Fellowship Class of 2028!
Hematology/Medical Oncology Fellowship Class of 2028!
December 4, 2024 at 10:57 PM
Congratulations to the @uamshealth
Hematology/Medical Oncology Fellowship Class of 2028!
Hematology/Medical Oncology Fellowship Class of 2028!
Reposted by Kostas Arnaoutakis
Great summary in @Annals_Oncology of an intensive few days in March 2024 discuss the key issues confronting lung cancer care globally, thanks to Dr. @mayluciemeyer for her excellent leadership on this manuscript! #lcsm @IASLC @myESMO
www.sciencedirect.com/science/arti...
www.sciencedirect.com/science/arti...
Lung cancer research and treatment: global perspectives and strategic calls to action
Lung cancer remains a critical public health issue, presenting multifaceted challenges in prevention, diagnosis, and treatment. This article aims to r…
www.sciencedirect.com
December 1, 2024 at 7:37 PM
Great summary in @Annals_Oncology of an intensive few days in March 2024 discuss the key issues confronting lung cancer care globally, thanks to Dr. @mayluciemeyer for her excellent leadership on this manuscript! #lcsm @IASLC @myESMO
www.sciencedirect.com/science/arti...
www.sciencedirect.com/science/arti...
Reposted by Kostas Arnaoutakis
Wishing Dr. Close @juliaclose.bsky.social much success in the years ahead as ASCO's Chief Education Officer connection.asco.org/magazine/fea...
A Career Shaped By Educators: Dr. Julia Close Shares Her Vision for ASCO’s Educational Programs
Dr. Julia Close shares how her commitment to oncology education drives her vision for innovation as she provides a deeper look into her upcoming plans as ASCO's chief education officer and executive v...
connection.asco.org
November 27, 2024 at 2:55 PM
Wishing Dr. Close @juliaclose.bsky.social much success in the years ahead as ASCO's Chief Education Officer connection.asco.org/magazine/fea...